Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In a controlled trial chloramphenicol proved as effective and much cheaper than penicillin for the treatment of group A meningococcal meningitis in Zaria, Nigeria. A short course of five days cured most patients. Adults and older children were soon able to take chloramphenicol by mouth, which reduced the cost and simplified treatment.It is suggested that chloramphenicol is a suitable alternative to sulphonamides for the treatment of meningococcal meningitis in those parts of Africa where the organism is sulphonamide-resistant.


Journal article


Br Med J

Publication Date





379 - 381


Administration, Oral, Cerebrospinal Fluid, Child, Child, Preschool, Chloramphenicol, Clinical Trials as Topic, Female, Hemagglutination Tests, Humans, Infant, Injections, Intramuscular, Male, Meningitis, Meningococcal, Neisseria meningitidis, Nigeria, Penicillin Resistance, Penicillins, Sulfonamides